A 25-year study of young adults transitioning to middle age revealed maintaining a healthy weight was more important in blood pressure control than four other health behaviors.

Amgen (NASDAQ:AMGN) today announced that a new analysis of the cardiovascular outcomes study (FOURIER) demonstrated that lowering low-density lipoprotein cholesterol (LDL-C) levels with Repatha® (evolocumab) significantly and consistently reduced cardiovascular events in patients with and without diabetes at baseline.

September 14, 2017 — A global team of researchers reported in the New England Journal of Medicine that the study did not meet its primary efficacy endpoint, but yielded important results for all-cause mortality.

Research presented at this year’s European Association of the Study of Diabetes conference in Portugal suggests middle-aged men with overweight or obese wives are more likely to develop type 2 diabetes—but the opposite doesn’t appear to be true for women with heavier husbands.

For years, medical professionals and media personalities alike have warned against sitting for prolonged periods, coining the phrase "sitting is the new smoking" to describe the health risks of a sedentary lifestyle. But how much is too much?

A group of Johns Hopkins scientists have uncovered a link between sleep apnea and cardiometabolic dysfunction that could help explain heart disease in sleep patients, according to a recent study.

New information out of an Australian research facility is cautioning pregnant women that any kind of hypertensive disorder of pregnancy during their term could result in cardiovascular complications in the future.

Empagliflozin tablets reduced the risk of cardiovascular death by 38 percent in people with type 2 diabetes and established cardiovascular disease (CVD), according to a randomized, placebo-controlled trial of more than 7,000 patients. And new analyses demonstrate a similar benefit was seen in all patients, regardless of blood sugar levels at baseline or after the introduction of background treatment.